Summary of dose-limiting toxicities and serious adverse events.

<p>AE, adverse event; DLT, dose-limiting toxicity (DLTs were defined as grade ≥3 infusion-related neurologic AEs and nonhematologic AEs not responsive to symptom-directed therapy); PR, probably related; PS, possibly related; NR, not related; TEAE, treatment-emergent adverse event.</p><p>Summary of dose-limiting toxicities and serious adverse events.